Pixyl.Neuro.MS
AI solution to support diagnosis and monitoring of multiple sclerosis (MS)
Pixyl.Neuro.MS is a tool assisting radiologists in the MRI diagnosis and follow-up of multiple sclerosis (MS) patients.
Pixyl.neuro.MS™ automatically analyses the MRI scan and provides a quantification of the lesion volume by identifying white matter hyperintensities.
Automatic detection, quantification and characterization of lesions in anatomical areas of interest
Pixyl.Neuro.MS measures the volume and lesion load for the entire brain and for every brain regions of interest (periventricular, juxtacortical, infratentorial, deep white matter) with regard to McDonald’s criteria (2017 revision)).
Longitudinal analysis of disease evolution if prior exam is present in the PACS
Pixyl.Neuro.MS automatically measures disease activity by segmenting and characterizing white matter evolution of lesions based on prior exams.
Automated production of a structured report and a segmented series (lesion outline) directly in the PACS
Pixyl.neuro provides the radiologist with a complete quantitative report on the lesions, their characteristics and evolution, as well as their visualization on the annotated brain images.
- multiple sclerosis
- T2 FLAIR
- T1 GADO
- lesion load
- MRI
- detection
- longitudinal analysis
Save time, reassure your diagnosis and streamline your workflow with Incepto
Testimonial
At the MAIL clinical group in Grenoble, we use Pixyl.Neuro.MS on FLAIR sequences for our multiple sclerosis patients.
The sensitivity of the algorithm is excellent, highlighting even the smallest lesions that would have been missed by the naked eye. Pixyl’s analysis is also valuable for high-lesion loads, enabling the detection of tiny variations of confluent lesions, thus improving their follow up.
The lesion-volume quantification offers a particularly useful rationalization for therapeutic decisions, thus improving patient care.
Dr Stéphane Cantin,
Neuroradiologist and president of the Mail clinical group
CHU Grenoble, France
Publications
- Benjamin Lambert and Maxime Louis and Senan Doyle and Florence Forbes and Michel Dojat and Alan Tucholka. “Leveraging 3D Information in Unsupervised Brain MRI Segmentation.” 2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI) (pp. 187-190). 2021
http://arxiv.org/abs/2101.10674 - Pauline Roca, Arnaud Attyé, Lucie Colas, Alan Tucholka, Pascal Rubini, Stenzel Cackowski, Juliette Ding, Jean-François Budzik, Felix Renard, Senan Doyle, Emmanuel L. Barbier, Imad Bousaid, Romain Casey, Sandra Vukusic, Nathalie Lassau, Sébastien Verclytte, and François Cotton. “Artificial intelligence to predict clinical disability status scale score in patients with multiple sclerosis using FLAIR MRI” Diagnostic and Interventional Imaging 2020.
https://doi.org/10.1016/j.diii.2020.05.009 - Alexander Robert W. “Use of Software Analytics of Brain MRI (with & without contrast) As Objective Metric in Neurological Disorders and Degenerative Diseases” 2017, International Physical Medicine & Rehabilitation Journal
https://doi.org/10.15406/ipmrj.2017.02.00046
Pixyl is a young French startup, founded in and based in Grenoble. Its management team comes from INSERM and INRIA. At the crossroads of medicine, data science and software development, Pixyl aims to revolutionise brain imaging by offering a quantified analysis of biomarkers of neurodegenerative and neuroinflammatory diseases. Their cutting-edge technology based on Deep Learning, allowed them to finish as winners of the French Society of Radiology’s 2019 Data Challenge.
The Pixyl.Neuro.MS medical device is a regulated healthcare product bearing the CE mark, Class IIa. Notified body: TÜV Rheinland. n°0197. Manufacturer: Pixyl.
Pixyl.Neuro.MS is a diagnostic aid and cannot be used on its own to recommend medical treatment for diagnostic purposes. Please read the user manual carefully.
Please contact contact@incepto-medical.com for further information. Last update : 26/03/2024